ctrl K

Watchlist Price Alert

Calidi Biotherapeutics In... (CLDI)

AMEX: CLDI · Real-Time Price · USD

0.41

-0.02 (-4.87%)

At close: May 08, 2025, 3:58 PM

0.46

10.47%

After-hours: May 08, 2025, 07:56 PM EDT

Calidi Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	45K	449K	n/a
Cost of Revenue	n/a	1.26M	274K	94K	n/a
Gross Profit	n/a	-1.26M	-229K	355K	n/a
Operating Income	-21.78M	-28.99M	-23.13M	-1.78M	-6.77M
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-22.2M	-29.2M	-25.42M	3.39M	-7.93M
Net Income	-22.14M	-29.22M	-25.43M	3.39M	-7.94M
Selling & General & Admin	12.9M	15.98M	15.64M	1.78M	3.59M
Research & Development	8.88M	13.01M	7.26M	4.67M	3.18M
Other Expenses	n/a	n/a	-5K	9K	4K
Operating Expenses	21.78M	28.99M	22.9M	1.78M	6.77M
Interest Expense	n/a	1.07M	158K	614K	163K
Selling & Marketing Expenses	n/a	n/a	-260K	-4.38M	n/a
Cost & Expenses	n/a	28.99M	23.17M	1.78M	6.77M
Income Tax Expense	14K	16K	11K	11K	4K
Shares Outstanding (Basic)	8.01M	16.89M	850.5K	2.88M	35.91M
Shares Outstanding (Diluted)	8.01M	1.69M	850.5K	2.88M	35.91M
EPS (Basic)	-2.97	-1.73	-29.9	1.18	-0.22
EPS (Diluted)	-2.97	-17.3	-29.9	1.18	-0.22
EBITDA	-21.78M	-27.58M	-25M	-9.45M	-6.65M
EBIT	-22.57M	-28.99M	-25.26M	-10.31M	-6.77M
Depreciation & Amortization	791K	1.26M	260K	153K	117K